Utility of Non-albumin Proteinuria for the Assessment of the Severity of Tubulointerstitial Inflammation in Lupus Nephritis Patients

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2025 Feb 18

PMID 39963635

Authors

Nur Jahan

Muhammad Rafiqul Alam

A K M Shahidur Rahman

S M Remin Rafi

S M Shamsuzzaman

Noureen Amin

Mamun Chowdhury Raju

Affiliations

Soon will be listed here.

Abstract

Background Lupus nephritis (LN) is the most common severe manifestation of systemic lupus erythematosus (SLE) that can involve all kidney components. The International Society of Nephrology/Renal Pathology Society (ISN/RPS) 2003 lupus nephritis classification only focuses on glomerular involvement, although tubulointerstitial inflammation (TI) is a better predictor of renal failure. Objective To determine the association of non-albumin proteinuria (NAP) and severity of tubulointerstitial inflammation in lupus nephritis patients. Methods This cross-sectional study was carried out in the Department of Nephrology of Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh. A total of eighty (80) LN patients were enrolled in this study. Their urinary protein-to-creatinine ratio (uPCR), urinary albumin-to-creatinine ratio (uACR), renal biopsy, and relevant routine investigations were done accordingly. Urinary non-albumin proteinuria (uNAP) was measured by subtracting uACR from uPCR. Data were analyzed and compared by statistical tests. Results Among 80 lupus nephritis patients, 39 (48.8%) had no-to-mild tubulointerstitial inflammation (TI), whereas 41 (51.2%) had moderate-to-severe tubulointerstitial inflammation. Proliferative glomerulonephritis (GN) (class III/class IV) was observed in 48 patients (60%), while non-proliferative GN (class II/V) was present in 32 patients (40%). In the logistic regression analysis, non-albumin proteinuria (uNAP) was found to be associated with moderate-to-severe tubulointerstitial inflammation (OR: 3.166, 95% CI: 1.145-8.757, p=0.026). The calculated cutoff value for uNAP was 887, which corresponds to a sensitivity of 96.7% and specificity of 76.0% (p<0.001). Conclusion Non-albumin proteinuria is associated with the severity of tubulointerstitial inflammation in lupus nephritis. Therefore, assessing non-albumin proteinuria can offer clinically valuable insights into the management of lupus nephritis.

References

Samarawickrama A, Cai M, Smith E, Nambiar K, Sabin C, Fisher M . Simultaneous measurement of urinary albumin and total protein may facilitate decision-making in HIV-infected patients with proteinuria. HIV Med. 2012; 13(9):526-32. DOI: 10.1111/j.1468-1293.2012.01003.x. View

Omokawa A, Wakui H, Okuyama S, Togashi M, Ohtani H, Komatsuda A . Predominant tubulointerstitial nephritis in a patient with systemic lupus erythematosus: phenotype of infiltrating cells. Clin Nephrol. 2008; 69(6):436-44. DOI: 10.5414/cnp69436. View

Hsieh C, Chang A, Brandt D, Guttikonda R, Utset T, Clark M . Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring. Arthritis Care Res (Hoboken). 2011; 63(6):865-74. PMC: 3106120. DOI: 10.1002/acr.20441. View

Brentjens J, Sepulveda M, Baliah T, Bentzel C, Erlanger B, Elwood C . Interstitial immune complex nephritis in patients with systemic lupus erythematosus. Kidney Int. 1975; 7(5):342-50. DOI: 10.1038/ki.1975.47. View

ODell J, Hays R, Guggenheim S, Steigerwald J . Tubulointerstitial renal disease in systemic lupus erythematosus. Arch Intern Med. 1985; 145(11):1996-9. View

Norden A, Lapsley M, Lee P, Pusey C, Scheinman S, Tam F . Glomerular protein sieving and implications for renal failure in Fanconi syndrome. Kidney Int. 2001; 60(5):1885-92. DOI: 10.1046/j.1523-1755.2001.00016.x. View

Weening J, DAgati V, Schwartz M, Seshan S, Alpers C, Appel G . The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 2004; 65(2):521-30. DOI: 10.1111/j.1523-1755.2004.00443.x. View

Gasparotto M, Gatto M, Binda V, Doria A, Moroni G . Lupus nephritis: clinical presentations and outcomes in the 21st century. Rheumatology (Oxford). 2020; 59(Suppl5):v39-v51. PMC: 7751166. DOI: 10.1093/rheumatology/keaa381. View

Nielsen R, Ilso Christensen E . Proteinuria and events beyond the slit. Pediatr Nephrol. 2010; 25(5):813-22. DOI: 10.1007/s00467-009-1381-9. View

10.

Smith E, Cai M, McMahon L, Wright D, Holt S . The value of simultaneous measurements of urinary albumin and total protein in proteinuric patients. Nephrol Dial Transplant. 2011; 27(4):1534-41. DOI: 10.1093/ndt/gfr708. View

11.

Houssiau F, Vasconcelos C, DCruz D, Sebastiani G, de Ramon Garrido E, Danieli M . Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial. Arthritis Rheum. 2004; 50(12):3934-40. DOI: 10.1002/art.20666. View

12.

Alsuwaida A . Interstitial inflammation and long-term renal outcomes in lupus nephritis. Lupus. 2013; 22(14):1446-54. DOI: 10.1177/0961203313507986. View

13.

Kwon O, Park Y, Lee J, Oh J, Kim Y, Lee C . Non-albumin proteinuria as a parameter of tubulointerstitial inflammation in lupus nephritis. Clin Rheumatol. 2018; 38(1):235-241. DOI: 10.1007/s10067-018-4256-2. View

14.

Chang D, Yeh H, Ting I, Lin C, Huang H, Chiang H . The ratio and difference of urine protein-to-creatinine ratio and albumin-to-creatinine ratio facilitate risk prediction of all-cause mortality. Sci Rep. 2021; 11(1):7851. PMC: 8041921. DOI: 10.1038/s41598-021-86541-3. View

15.

Pagni F, Galimberti S, Galbiati E, Rebora P, Pietropaolo V, Pieruzzi F . Tubulointerstitial lesions in lupus nephritis: International multicentre study in a large cohort of patients with repeat biopsy. Nephrology (Carlton). 2015; 21(1):35-45. DOI: 10.1111/nep.12555. View

16.

Steinmetz O, Velden J, Kneissler U, Marx M, Klein A, Helmchen U . Analysis and classification of B-cell infiltrates in lupus and ANCA-associated nephritis. Kidney Int. 2008; 74(4):448-57. DOI: 10.1038/ki.2008.191. View

17.

Chang A, Henderson S, Brandt D, Liu N, Guttikonda R, Hsieh C . In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis. J Immunol. 2010; 186(3):1849-60. PMC: 3124090. DOI: 10.4049/jimmunol.1001983. View

18.

Yu F, Wu L, Tan Y, Li L, Wang C, Wang W . Tubulointerstitial lesions of patients with lupus nephritis classified by the 2003 International Society of Nephrology and Renal Pathology Society system. Kidney Int. 2010; 77(9):820-9. DOI: 10.1038/ki.2010.13. View

19.

Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R . 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019; 71(9):1400-1412. PMC: 6827566. DOI: 10.1002/art.40930. View

20.

Mok C, Tang S . Incidence and predictors of renal disease in Chinese patients with systemic lupus erythematosus. Am J Med. 2004; 117(10):791-5. DOI: 10.1016/j.amjmed.2004.04.029. View